Enterome’s Investigational EB8018 for Crohn’s is Found Safe in Phase 1 Trial
News
Enterome Bioscience’s EB8018, a potential new therapy for Crohn’s disease, was well-tolerated by healthy volunteers in a Phase 1 clinical trial. EB8018 targets the gut microbiome (the gut includes the ... Read more